8-K: Hims & Hers Health Stockholders Overwhelmingly Approve All Proposals at Annual Meeting

Hims & Hers Health, Inc. announced that its stockholders approved all three proposals, including the election of directors, ratification of KPMG LLP, and advisory approval of executive compensation, at its Annual Meeting held on June 12, 2025.

Summary

• Hims & Hers Health, Inc. held its Annual Meeting of Stockholders on June 12, 2025.
• Stockholders of record as of April 14, 2025, were entitled to vote, with 215,254,280 shares of Class A Common Stock (one vote per share) and 8,377,623 shares of Class V Common Stock (175 votes per share) outstanding.
• All three proposals presented at the Annual Meeting were approved by the stockholders.
• Proposal 1, the election of directors, saw all ten nominated individuals receive substantial 'For' votes, indicating strong shareholder support for the board.
• Proposal 2, the ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was approved with 1,610,376,984 'For' votes.
• Proposal 3, the advisory approval of the Company's executive compensation, was also approved with 1,528,328,634 'For' votes.

Sentiment

Score: 8

Explanation: The overwhelming approval of all management-backed proposals, including director elections, auditor ratification, and executive compensation, indicates strong shareholder confidence and alignment with the company's current strategic direction and governance.

Positives

• All three proposals presented at the Annual Meeting received overwhelming shareholder approval, demonstrating strong investor confidence in the company's governance and management.
• The election of all nominated directors passed with significant 'For' votes, ensuring continuity and stability in the company's leadership.
• The ratification of KPMG LLP as the independent auditor for 2025 passed with substantial support, indicating shareholder comfort with the company's financial oversight.
• The advisory approval of executive compensation signals shareholder alignment with the current compensation structure and practices.

Future Outlook

The document does not provide specific forward-looking statements or financial guidance, focusing solely on the results of the Annual Meeting of Stockholders.

Management Comments

• Andrew Dudum, Chief Executive Officer, signed the report on behalf of Hims & Hers Health, Inc.

Industry Context

This 8-K filing is a procedural update on shareholder voting results and does not contain information directly related to broader industry trends or competitive landscape within the telehealth or healthcare technology sectors.

Corporate Governance

Stakeholder Impact

• Shareholders: The approval of all proposals indicates strong shareholder support for the current management and governance, potentially leading to continued stability.
• Management: The overwhelming votes in favor of director elections and executive compensation provide a clear mandate and validation for the current leadership team and their compensation structure.

Next Steps

• The elected directors will serve until the next annual meeting of stockholders (presumably in 2026) and until their respective successors are duly elected and qualified.

Key Dates

Recommendation

Keywords

Hims & Hers Health, HIMS, SEC Filing, 8-K, Annual Meeting, Stockholder Vote, Corporate Governance, Director Election, Auditor Ratification, Executive Compensation, Shareholder Approval